Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals.

by Heimo Lagler, Katharina Grabmeier-Pfistershammer, Veronique Touzeau-Römer, Selma Tobudic, Michael Ramharter, Judith Wenisch, Guido Andrés Gualdoni, Monika Redlberger-Fritz, Theresia Popow-Kraupp, Armin Rieger, Heinz Burgmann
Published 2012-01-01